Skip to content

Body composition and neurodevelopment in preterm infants

Body composition and neurodevelopment in preterm infants

Status
Recruiting
Phases
Unknown
Study type
Unknown
Source
NL-OMON
Registry ID
NL-OMON21514
Enrollment
150
Registered
2016-07-21
Start date
2014-09-14
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

preterm infants body composition neurodevelopmental outcome nutrition

Interventions

not applicable - observational trial

Sponsors

Erasmus MC - Sophia Children's Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Preterm birth < 30 weeks of gestation Admission to NICU within 48 hours after birth Written informed consent

Exclusion criteria

Exclusion criteria: Severe brain injury (IVH gr III/IV, post-hemorrhagic ventricular dilatation) Perinatal asphyxia (pH < 7.00 and 5' min APGAR score <5) Congenital TORCHES infection Chromosomal abnormalities Severe congenital anomalies

Design outcomes

Primary

MeasureTime frame
Body composition (percentage body fat) at 2 years corrected age Neurodevelopmental outcome assessed by Bayley Scales of Infant and Toddler Development (mental and motor outcome measures) and eye-tracker at 2-years corrected age

Secondary

MeasureTime frame
Body composition at term-equivalent age, 6-weeks, 6-months corrected age. Brain growth at 6-weeks corrected age. Microbiome at 2-years corrected age. Blood pressure at 2-years corrected age

Contacts

Public ContactJorine A. Roelants

Wytemaweg 80

j.roelants@erasmusmc.nl+31 10 7036015

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)